AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake

Authors

Ramachandran Rashmi, Washington University School of Medicine in St. Louis
Carl DeSelm, Washington University School of Medicine in St. Louis
Cynthia Helms, Washington University School of Medicine in St. Louis
Anne Bowcock, Washington University School of Medicine in St. LouisFollow
Buck E. Rogers, Washington University School of Medicine in St. Louis
Janet Rader, Medical College of Wisconsin, Milwaukee
Perry W. Grigsby, Washington University School of Medicine in St. LouisFollow
Julie K. Schwarz, Washington University School of Medicine in St. Louis

Journal

PLoS One

Publication Date

2014

Volume

9

Issue

4

Inclusive Pages

e92948

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0092948

Rights and Permissions

Rashmi R, DeSelm C, Helms C, Bowcock A, Rogers BE, et al. (2014) AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake. PLoS ONE 9(4): e92948. doi: 10.1371/journal.pone.0092948

Recommended Citation

Rashmi, Ramachandran; DeSelm, Carl; Helms, Cynthia; Bowcock, Anne; Rogers, Buck E.; Rader, Janet; Grigsby, Perry W.; and Schwarz, Julie K., "AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake." PLoS One. 9, 4. e92948. (2014).
https://digitalcommons.wustl.edu/open_access_pubs/2825